Sarah E. Dixon-Clarke

Statistics

Publications

Citations

492

H-Index

Active since

2015

Affiliations

Genomics (United Kingdom)(Current)

Boston University

Dana-Farber Cancer Institute

University of Oxford

Harvard University

Sarah E. Dixon-Clarke is an author at Genomics (United Kingdom) specializing in cyclin-dependent kinases, structural biology, and protein kinase cascades.

Publications per year

2015–2022

Publications

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

Tinghu Zhang, Nicholas Kwiatkowski, Sarah E. Dixon-Clarke et al. · Nature Chemical Biology · 2016 · 372 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +16

Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16

Sarah E. Dixon-Clarke, Saifeldin N. Shehata, T. Krojer et al. · Biochemical Journal · 2017 · 60 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +15

Structures of the CDK12/CycK complex with AMP-PNP reveal a flexible C-terminal kinase extension important for ATP binding

Sarah E. Dixon-Clarke, Jonathan M. Elkins, Siwei Cheng et al. · Scientific Reports · 2015 · 37 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits

Jessica W. Tsai, Paloma Cejas, Dayle K. Wang et al. · Cancer Research · 2022 · 23 citations · Full text

Medicine, Genetics, Oncology +16

1–4 of 4